Faculty Bibliography

PURPOSE: To assess the utility of apparent diffusion coefficient (ADC) values obtained from diffusion-weighted imaging (DWI) in distinguishing high-grade bladder cancer with and without metastatic disease. MATERIALS AND METHODS: Seventeen patients with histologically confirmed high-grade bladder cancer who underwent pelvic magnetic resonance imaging (MRI) at 1.5T including DWI using b-values of 0, 400, and 800 sec/mm(2) were assessed. Histologic findings and follow-up imaging were used to establish the reference standard in terms of metastatic disease. Two radiologists independently recorded ADC of all lesions following a training session, with their results averaged. Mann-Whitney U-test, receiver operating characteristic (ROC) curve analysis and intraclass correlation coefficient (ICC) were used for data analysis. RESULTS: Metastatic disease was characterized as present or absent in eight and nine patients, respectively. ADC was significantly lower among cases with metastatic disease than among cases without metastatic disease, both within the entire cohort (1.07 +/- 0.18 x 10(-3) mm(2) /s vs. 1.45 +/- 0.22 x 10(-3) mm(2) /s; P = 0.002) and within the subset of patients with muscle-invasive tumor (1.06 +/- 0.19 x 10(-3) mm(2) /s vs. 1.45 +/- 0.23 x 10(-3) mm(2) /s; P = 0.017). Area under the ROC curve for identifying metastatic disease using ADC was 0.944, with optimal threshold of 1.21 x 10(-3) mm(2) /s, which was associated with a sensitivity of 87.5%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 90.0%. Interreader agreement for ADC was excellent (ICC = 0.91). CONCLUSION: In this preliminary study, ADC was significantly different between cases of high-grade urothelial carcinoma of the bladder with and without metastatic disease. These results may have value in assessing the metastatic potential of patients with localized high-grade tumors of the bladder. J. Magn. Reson. Imaging 2012;. (c) 2012 Wiley Periodicals, Inc.

OBJECTIVE: The purposes of this study were to describe the spectrum of cross-sectional imaging findings of pathologically proven hepatoportal sclerosis and to compare the features of advanced and nonadvanced hepatoportal sclerosis. MATERIALS AND METHODS: Eighteen patients with a histopathologic diagnosis of hepatoportal sclerosis who had concurrent MRI or CT images participated in the study. The following imaging features were assessed: presence of liver nodularity and liver lesions, portal vein patency, presence and degree of portal hypertension, liver volume, and caudate-to-right lobe ratio. These features were compared between patients who underwent transplant and those who did not. RESULTS: The 18 patients (11 men and one boy, six women; mean age, 46.5 years) had hepatoportal sclerosis confirmed with liver biopsy (14 patients) or explant (four patients). Fourteen patients underwent contrast-enhanced MRI, and five underwent CT. The imaging findings were as follows: liver surface nodularity, five patients (all four transplant, one nontransplant) (p = 0.0016); evidence of portal hypertension, 17 patients; increased caudate-to-right lobe ratio, 16 patients; high periportal signal intensity on T2-weighted images, six patients; portal vein occlusion with cavernous transformation, five patients. The transplant patients had smaller pretransplant liver volume than did nontransplant patients (p < 0.04). CONCLUSION: Hepatoportal sclerosis is characterized by caudate lobe hypertrophy and right hepatic lobe atrophy, preserved liver volume, and lack of the liver nodularity associated with portal hypertension. In advanced cases, liver nodularity and atrophy produce an imaging appearance indistinguishable from that of cirrhosis.

OBJECTIVE: The purpose of this study was to retrospectively correlate the imaging and pathologic features of multilocular cystic renal cell carcinoma (RCC), a low-grade neoplasm that has an excellent prognosis. MATERIALS AND METHODS: Institutional databases were searched for the period between 2001 and 2010 to identify cases of resected renal tumors that had been evaluated with CT or MRI and been analyzed by a uropathologist to confirm the histologic diagnosis of multilocular cystic RCC. The images (nine CT, 14 MRI) were reviewed, and a Bosniak cyst category was assigned. RESULTS: Of 23 confirmed cases of multilocular cystic RCC, imaging revealed seven lesions were Bosniak category IIF, 13 were category III, and three were category IV. Pathologic examination of the category IIF lesions revealed 99% fluid, 0.001-1% clear cells lining the septum, and 0% fibrosis. The category III lesions were 98-99% fluid, 1-2% clear cells, and 0% fibrosis. The category IV lesions were 20-40% fluid, 1-5% clear cells, and 60-80% fibrosis. The patient demographics were similar across groups. Clinical follow-up showed no evidence of recurrent or metastatic disease. CONCLUSION: Multilocular cystic RCC is a rare cystic lesion of the kidney that is low risk to the patient and benign in behavior. It has a variable imaging pattern, the Bosniak category ranging from IIF to IV. As multilocular cystic RCC lesions increase in complexity on images (higher Bosniak category), there is a corresponding increase in the volume of malignant cells lining the tumor and an increase in the presence of vascularized fibrous tissue. Regardless of the imaging appearance, the behavior of these tumors was benign in this study. Clinicians and radiologists should be aware that when this carcinoma is reported to occur, the patient has an excellent prognosis.

Purpose: To retrospectively assess the relationships between a number of magnetic resonance (MR) imaging features and growth rate of solid renal masses in patients undergoing active surveillance. Materials and Methods: This retrospective study was institutional review board approved, with waiver of informed consent. This study was HIPAA compliant. Forty-four patients (mean age, 70 years +/- 13 [standard deviation]; 31 men, 13 women) with 47 solid renal masses measuring at least 1 cm who underwent two contrast material-enhanced MR imaging studies at least 3 months apart were included. The initial MR imaging study was evaluated independently by two radiologists for an array of imaging features, with differences resolved by consensus. Later, the two readers in consensus measured tumor volume on the first and last study to calculate tumor doubling time (DT). Associations between MR imaging features and DT were assessed by using generalized estimating equations and mixed model analyses. Interreader agreement was assessed with k coefficients. Results: kappa coefficients ranged from 0.62 to 0.92. Mean DT of the 47 masses was 530 days. Five (11%) masses decreased in size. Twenty-five of 47 masses were classified as slow growing on the basis of a DT of more than 2 years. There was significantly slower growth among masses showing homogeneity on T2-weighted images (P = .036) and a nearly significant slower growth rate among masses showing homogeneity on postcontrast images (P = .065) and hypointensity on T2-weighted images (P = .074). There was a significant correlation between initial volume and growth rate among lesions larger than 3 cm (r = 0.79, P = .041) but not among smaller lesions (r = -0.02, P = .911). Multivariate analysis identified age (odds ratio = 0.92, P = .015) and homogeneity on T2-weighted images (odds ratio = 4.47, P = .037) as independent predictors of slow growth. Conclusion: The results suggest MR imaging features may have a role in predicting growth rate of solid renal masses during active surveillance. (c) RSNA, 2012 Supplemental material: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.11111074/-/DC1.

Purpose: To evaluate the ability of magnetization transfer (MT) contrast-prepared magnetic resonance (MR) imaging to help distinguish healthy from cirrhotic liver by using a spectrum of MT pulse frequency offsets. Materials and Methods: This HIPAA-compliant prospective study was approved by the institutional review board. Written informed consent was obtained from all subjects. After optimization of the MT sequence by using agar phantoms with protein concentrations ranging from 0% to 4%, 20 patients with cirrhosis and portal hypertension and 20 healthy volunteers with no known liver disease underwent liver MR imaging that included eight separate breath-hold MT contrast sequences, each performed by using a different MT pulse frequency offset (range, 200-2500 Hz). Regions of interest were then placed to calculate the MT ratio for the liver, fat, and muscle in the volunteer group and for the liver in the cirrhosis group. Results: MT ratio increased with decreasing MT pulse frequency offset for each of the four phantoms and the assessed in vivo tissues, consistent with previous reports. At all frequency offsets, MT ratio increased with increasing phantom protein concentration. In volunteers, at frequency offsets greater than 400 Hz, the MT ratio was significantly greater for muscle (range, 34.4%-54.9%) and significantly lower for subcutaneous fat (range, 10.3%-12.6%), compared with that for the liver (range, 22.8%-46.9%; P < .001 all comparisons). However, the MT ratio was nearly identical between healthy (range, 26.0%-80.0%) and cirrhotic livers (range, 26.7%-81.2%) for all frequency offsets (P = .162-.737), aside from a minimal difference in MT ratio of 1.7% at a frequency offset of 2500 Hz (22.8% in healthy liver vs 24.5% in cirrhotic liver) that was not significant when the Bonferroni correction was applied (P = .015). Conclusion: Findings of this study confirm the ability of the MT contrast-prepared sequence to help distinguish substances of varying protein concentration and suggest that MT imaging is unlikely to be of clinical utility in differentiating healthy and cirrhotic livers. (c) RSNA, 2011

PURPOSE: To assess the utility of a 3D two-point Dixon sequence with water-fat decomposition for quantification of fat content of renal angiomyolipoma (AML). METHODS: 84 patients underwent renal MRI including 2D in-and-opposed-phase (IP and OP) sequence and 3D two-point Dixon sequence that generates four image sets [IP, OP, water-only (WO), and fat-only (FO)] within one breath-hold. Two radiologists reviewed 2D and 3D images during separate sessions to identify fat-containing renal masses measuring at least 1cm. For identified lesions subsequently confirmed to represent AML, ROIs were placed at matching locations on 2D and 3D images and used to calculate 2D and 3D SI(index) [(SI(IP)-SI(OP))/SI(IP)] and 3D fat fraction (FF) [SI(FO)/(SI(FO)+SI(WO))]. 2D and 3D SI(index) were compared with 3D FF using Pearson correlation coefficients. RESULTS: 41 AMLs were identified in 6 patients. While all were identified using the 3D sequence, 39 were identified using the 2D sequence, with the remaining 2 AMLs retrospectively visible on 2D images but measuring under 1cm. Among 32 AMLs with a 3D FF of over 50%, both 2D and 3D SI(index) showed a statistically significant inverse correlation with 3D FF (2D SI(index): r=-0.63, p=0.0010; 3D SI(index): r=-0.97, p<0.0001). CONCLUSION: 3D two-point Dixon sequence may provide a reasonable alternative to 2D dual-echo sequence for detection of renal AML and may have additional value for quantification of fat content of these lesions given the observation that 3D FF, unlike 2D and 3D SI(index), is not limited by ambiguity of water or fat dominance. This may assist clinical management of AML given evidence that fat content predicts embolization response

AIM: To compare image quality and lesion detection in the liver using magnetic resonance imaging (MRI) at 3T between T2-weighted imaging using a standard rectilinear k-space trajectory (standard T2WI) and using the BLADE technique (BLADE-T2WI), a technique that employs periodically rotated overlapping parallel lines with enhanced reconstruction for motion correction. MATERIALS AND METHODS: Twenty-eight consecutive patients who underwent MRI examination of the liver at 3T including standard T2WI and BLADE-T2WI, both performed using multiple breath-holds, comprised the study cohort. Images were reviewed in consensus by two radiologists during separate sessions for a number of measures regarding artefacts and image quality. These two readers also assessed the two image sets for the presence of liver lesions and measured liver-to-lesion contrast. Binary logistic regression for correlated data was used to compare the sequences in terms of sensitivity and positive predictive value (PPV) for lesion detection. RESULTS: BLADE-T2WI received significantly higher scores than did standard T2WI for in-plane respiratory motion (p=0.0195), other ghosting artefacts (p<0.0001), sharpness of the liver edge (p=0.0004), sharpness of intra-hepatic vessels (p<0.0001), flow signal suppression (p<0.0001), and overall image quality (p<0.0001). There was a non-significant trend toward improved B(1)-inhomogeneity artefact with BLADE-T2WI (p=0.0571). There was no difference in through-plane respiratory motion (p=0.6836). BLADE-T2WI demonstrated a significant improvement in PPV for lesion detection (p=0.0129) as well as in liver-to-lesion contrast (p=0.0054). There was no difference regarding lesion sensitivity (p=1.0). CONCLUSIONS: Use of the BLADE technique for T2-weighted MRI of the liver at 3T may lead to a significant improvement in image artefacts and improved PPV for lesion detection

OBJECTIVE:: To compare free-breathing radially sampled 3D fat suppressed T1-weighted gradient-echo acquisitions (radial volumetric interpolated breath-hold examination [VIBE]) with breath-hold (BH) and free-breathing conventional (rectilinearly sampled k-space) VIBE acquisitions for postcontrast imaging of the liver. MATERIALS AND METHODS:: Eighteen consecutive patients referred for clinically indicated liver magnetic resonance imaging were imaged at 3 T. Three minutes after a single dose of gadolinium contrast injection, free-breathing radial VIBE, BH VIBE, and free-breathing VIBE with 4 averages were acquired in random order with matching sequence parameters. Radial VIBE was acquired with the 'stack-of-stars' scheme, which uses conventional sampling in the slice direction and radial sampling in-plane.All image data sets were evaluated independently by 3 radiologists blinded to patient and sequence information. Each reader scored the following parameters: overall image quality, respiratory motion artifact, pulsation artifact, liver edge sharpness, and hepatic vessel clarity using a 5-point scale, with the highest score indicating the most optimum examination. Mixed model analysis of variance was used to compare sequences in terms of each measure of image quality. RESULTS:: When scores were averaged over readers, there was no statistically significant difference between radial VIBE and BH VIBE regarding overall image quality (P = 0.1015), respiratory motion artifact (P = 1.0), and liver edge sharpness (P = 0.2955). Radial VIBE demonstrated significantly lower pulsation artifact (P < 0.0001), but had lower hepatic vessel clarity (P = 0.0176), when compared with BH VIBE. Radial VIBE had significantly higher image quality scores for all parameters when compared with free-breathing VIBE (P < 0.0001). Acquisition time for BH VIBE was 14 seconds and that of free-breathing radial VIBE and conventional VIBE with multiple averages was 56 seconds each. CONCLUSION:: Radial VIBE can be performed during free breathing for contrast-enhanced imaging of the liver with comparable image quality to BH VIBE. However, further work is necessary to shorten the acquisition time to perform dynamic imaging

OBJECTIVE: The purpose of this article is to review the roles that MRI is expected to play in emerging minimally invasive focal ablative therapies for prostate cancer. CONCLUSION: MRI, in combination with biopsy, will impact patient selection for focal ablation by helping to localize clinically significant tumor foci. Also, some ablation procedures may be performed using real-time MRI guidance. In addition, MRI may be used for assessment of extent of necrosis shortly after therapy and for long-term surveillance for recurrent tumor

Osteoclastoma-like giant cell tumor of the renal pelvis, similar to the entity more commonly occurring in bone, is very rare, having been reported in twelve previous cases to our knowledge. This is the first report of this entity, to our knowledge, to include its cross-sectional imaging appearance. A hyperdense area within the lesion on non-contrast CT may correspond with extensive hemorrhagic content of the lesion identified histologically. As in most prior cases, an adjacent smaller urothelial carcinoma of the renal pelvis was also identified. In the limited reported cases, this entity has exhibited highly aggressive behavior with poor prognosis